These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 802636)

  • 1. Central sympathetic transmitters and hypertension.
    Henning M
    Clin Sci Mol Med Suppl; 1975 Jun; 2():195s-203s. PubMed ID: 802636
    [No Abstract]   [Full Text] [Related]  

  • 2. Centrally induced hypotension by alpha-methyldopa and alpha-methylnoradrenaline in normotensive and renal hypertensive rats.
    Nijkamp FP; De Jong W
    Prog Brain Res; 1977; 47():349-68. PubMed ID: 337354
    [No Abstract]   [Full Text] [Related]  

  • 3. SOME OBSERVATIONS ON THE PHARMACOLOGY OF ALPHA-METHYLDOPA.
    DAY MD; RAND MJ
    Br J Pharmacol Chemother; 1964 Feb; 22(1):72-86. PubMed ID: 14126060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the mechanism of the cardiovascualr effects of methyldopa.
    Lokhandwala MF; Buckley JP; Jandhyala BS
    Eur J Pharmacol; 1976 May; 37(1):79-89. PubMed ID: 6292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive action of clonidine (Catapresan).
    van Zwieten AP
    Contrib Nephrol; 1977; 8():200-12. PubMed ID: 196810
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of clonidine and methyldopa on blood pressure and side effects in hypertensive patients.
    Putzeys MR; Hoobler SW
    Am Heart J; 1972 Apr; 83(4):464-8. PubMed ID: 5041833
    [No Abstract]   [Full Text] [Related]  

  • 7. Absence of an effect of mianserin on the actions of clonidine or methyldopa in hypertensive patients.
    Elliott HL; McLean K; Sumner DJ; Reid JL
    Eur J Clin Pharmacol; 1983; 24(1):15-9. PubMed ID: 6299752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of the relative potencies of norepinephrine and alpha-methylnoradrenaline for the mode of action of alpha-methyldopa.
    Trinker FR
    J Pharm Pharmacol; 1971 Apr; 23(4):306-8. PubMed ID: 4396912
    [No Abstract]   [Full Text] [Related]  

  • 9. Neurogenic hypertension, with special reference to the central neurogenic effects of angiotensin.
    Dickinson CJ
    Circ Res; 1970 Oct; 27():Suppl 2:169+. PubMed ID: 4319093
    [No Abstract]   [Full Text] [Related]  

  • 10. [New concepts on central regulation of the blood pressure. Mode of action of clonidine and alpha-methyl DOPA (author's transl)].
    Kobinger W
    Wien Klin Wochenschr; 1977 Apr; 89(8):253-7. PubMed ID: 193305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. General pharmacology of the novel centrally acting antihypertensive agent moxonidine.
    Armah BI; Hofferber E; Stenzel W
    Arzneimittelforschung; 1988 Oct; 38(10):1426-34. PubMed ID: 3196383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of noradrenergic and serotonergic neurons to the circulatory effects of centrally acting clonidine and alpha-methyldopa in rabbits.
    Head GA; Korner PI; Lewis SL; Badoer E
    J Cardiovasc Pharmacol; 1983; 5(6):945-53. PubMed ID: 6196566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methyldopa and neural control of circulation in essential hypertension.
    Mancia G; Ferrari A; Gregorini L; Bianchini C; Terzoli L; Leonetti G; Zanchetti A
    Am J Cardiol; 1980 Jun; 45(6):1237-43. PubMed ID: 6990740
    [No Abstract]   [Full Text] [Related]  

  • 14. The plasma noradrenaline and growth hormone response to alpha-methyldopa and clonidine in hypertensive subjects.
    Struthers AD; Brown MJ; Adams EF; Dollery CT
    Br J Clin Pharmacol; 1985 Mar; 19(3):311-7. PubMed ID: 3986086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The central action of antihypertensive drugs, mediated via central alpha-receptors.
    van Zwieten PA
    J Pharm Pharmacol; 1973 Feb; 25(2):89-95. PubMed ID: 4146560
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemodynamic changes in long-term -methyldopa therapy of essential hypertension.
    Lund-Johansen P
    Acta Med Scand; 1972 Sep; 192(3):221-6. PubMed ID: 5055268
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiovascular functions of central noradrenergic and serotonergic neurons in conscious rabbits. Their contributions to the central actions of clonidine.
    Korner PI; Head GA
    Chest; 1983 Feb; 83(2 Suppl):335-8. PubMed ID: 6401613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of clonidine on sympathetic function.
    Bravo EL
    Chest; 1983 Feb; 83(2 Suppl):369-71. PubMed ID: 6337029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central noradrenergic control of blood pressure.
    Scriabine A; Clineschmidt BV; Sweet CS
    Annu Rev Pharmacol Toxicol; 1976; 16():113-23. PubMed ID: 7183
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent developments in noradrenergic neurotransmission and its relevance to the mechanism of action of certain antihypertensive agents.
    Langer SZ; Cavero I; Massingham R
    Hypertension; 1980; 2(4):372-82. PubMed ID: 6105128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.